Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction. - Wikidata - awgldk - TriplyDB

Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.

Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.

http://www.wikidata.org/entity/Q39927735

about

p38 MAPK in cardioprotection - are we there yet?Delivering regenerative cues to the heart: cardiac drug delivery by microspheres and peptide nanofibers.Molecular imaging in atherosclerosis, thrombosis, and vascular inflammation.Intramyocardial injection of platelet gel promotes endogenous repair and augments cardiac function in rats with myocardial infarction.The delivery of superoxide dismutase encapsulated in polyketal microparticles to rat myocardium and protection from myocardial ischemia-reperfusion injury.Surface functionalization of polyketal microparticles with nitrilotriacetic acid-nickel complexes for efficient protein capture and delivery.The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure.Targeting extracellular DNA to deliver IGF-1 to the injured heart N-acetylglucosamine conjugated to nanoparticles enhances myocyte uptake and improves delivery of a small molecule p38 inhibitor for post-infarct healing.Nanoparticles targeting the infarcted heart Biomaterial-mediated modification of the local inflammatory environment.Signaling via the kinase p38α programs dendritic cells to drive TH17 differentiation and autoimmune inflammation Micro- and Nanoparticles for Treating Cardiovascular Disease.Sensing the cardiac environment: exploiting cues for regeneration Acetal-modified dextran microparticles with controlled degradation kinetics and surface functionality for gene delivery in phagocytic and non-phagocytic cells.Modulation of p38 kinase by DUSP4 is important in regulating cardiovascular function under oxidative stress Bioactive nanoparticles improve calcium handling in failing cardiac myocytes.Dual delivery of hepatocyte and vascular endothelial growth factors via a protease-degradable hydrogel improves cardiac function in rats.Caveolin and β1-integrin coordinate angiotensinogen expression in cardiac myocytes Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction Disruption of TAB1/p38α interaction using a cell-permeable peptide limits myocardial ischemia/reperfusion injury.Do p38 mitogen-activated protein kinase inhibitors have a future for the treatment of cardiovascular disease?PLGA-PNIPAM Microspheres Loaded with the Gastrointestinal Nutrient NaB Ameliorate Cardiac Dysfunction by Activating Sirt3 in Acute Myocardial Infarction Tunable protein release from acetalated dextran microparticles: a platform for delivery of protein therapeutics to the heart post-MI.Novel insights for systemic inflammation in sepsis and hemorrhage.Multifunctional dendritic polymers in nanomedicine: opportunities and challenges.Role of p38 inhibition in cardiac ischemia/reperfusion injury.Therapeutic strategies based on polymeric microparticles.Nanoscale assemblies and their biomedical applications.Therapeutic application of nanotechnology in cardiovascular and pulmonary regeneration.Smart chemistry in polymeric nanomedicine.Physicobiological properties and biocompatibility of biodegradable poly(oxalate-co-oxamide).Light-triggered chemical amplification to accelerate degradation and release from polymeric particles.Age- and chamber-specific differences in oxidative stress after ischemic injury.Multifunctional folate receptor-targeting and pH-responsive nanocarriers loaded with methotrexate for treatment of rheumatoid arthritis.Temporal effects of catalase overexpression on healing after myocardial infarction.Substituent Effects on the pH Sensitivity of Acetals and Ketals and Their Correlation with Encapsulation Stability in Polymeric Nanogels.Protective effect of magnolol-loaded polyketal microparticles on lipopolysaccharide-induced acute lung injury in rats.Delivery of alginate-chitosan hydrogel promotes endogenous repair and preserves cardiac function in rats with myocardial infarction.Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA induces homology-directed DNA repair

P2860

Q27001653-06AB3527-308B-47EB-ACA8-D11EA0447B29 Q30473970-9D84D8B6-8747-46FF-8160-AF9986319FEF Q30484224-3AFE7F3C-F7EC-4B2A-A4C1-B23BC8A30B51 Q30536488-C2214C66-EC48-441D-9199-86D4EDC58863 Q33620882-77E04165-8BB6-4099-A9BB-D92A6387328B Q33837244-0ABFF604-F838-4867-B510-CD29C6C7BDAB Q34148893-EE750276-EEFD-4996-801F-3628362A2BC7 Q35113470-10AD9C46-E272-4791-92F9-4DADFED5DB5B Q35223815-F40002ED-AD07-4796-88B0-24A59AB416CB Q35332320-189457DA-BFD8-4E09-8447-FB69125815ED Q35609496-95AA6935-F6EB-4DBC-962D-7E045C3D5A42 Q35685580-6392CF4B-F8B6-4374-AE1C-CBCE272D8105 Q35801354-3F96147D-A5B7-415E-8194-33A4FB32B206 Q35906866-B5C4917B-70D7-4015-B87B-6B4B9369DAD8 Q36047076-1F1704B9-3140-4453-8CCB-7925AF49A84F Q36386379-7BE9945C-BF7A-4A9D-B765-9EC83B5F9C43 Q36421703-A45DD0F8-C7C6-450E-BD27-6416B33E1B31 Q36437704-AC301DB9-3BC3-4C19-8A94-CD1B0AECB5EC Q36617132-E8897F3B-AD3C-46EB-AE5C-57755FAB2DB6 Q37155836-10D620CA-8F58-4557-AEED-F9A3567DB228 Q37181412-5F56A63A-6BA0-4D6A-9B58-F6B96A614A37 Q37329529-2744D32C-2526-4A41-B7B6-34A5E1F99162 Q37505129-CE97E32E-F6B1-4A8E-AADB-75DD3A4C5C66 Q37542987-5F417A60-014E-48C8-B66F-01C427E504DE Q37772404-DE1B1008-4D9D-4F26-9D60-B6C29887D13C Q37967150-7045E8F7-261A-4236-9110-908D2D3AA5E5 Q37972088-68E5AA78-9063-49E2-B630-9B490704CA4C Q38016146-AE2ADB95-8FDA-4939-AF2B-E632C12890E1 Q38072847-EAA3982A-EAC7-4E52-B209-83822FE14314 Q38201046-B78664AF-22F0-41D1-AA0A-743B8EC95A91 Q38221776-2D7A4E84-A719-48E2-B26A-0780CA10D9ED Q39522835-AB0448CC-AEBE-407E-A145-62B11EC00A1A Q39842118-EB588E52-DD60-4B5B-B019-2DFE9285E38C Q41571431-B8B6F1B5-E16A-4B17-A331-BE4CD9D82007 Q41714062-B253F720-53B5-46D0-B7BE-AE39C0B22DFD Q42716255-CF1FC983-641E-423D-B3F1-532DC8EAEF6B Q48330249-CBA6EB13-E64E-48EB-AA47-484E162C51DA Q51274597-834AE835-E40A-4B1A-8187-4866F73B30D5 Q51735425-01FC4239-8951-48FB-97BF-DD6C4EAB98CA Q58054257-E828F634-9DEF-42B6-A47C-6DE9B5C9C414

P2860

Sustained release of a p38 inhibitor from non-inflammatory microspheres inhibits cardiac dysfunction.

http://www.wikidata.org/entity/Q39927735

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@en

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@nl

type

label

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@en

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@nl

prefLabel

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@en

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@nl

P1433

Q39927735-87B1C001-152D-46A6-8D30-A3084500390E

P1476

Q39927735-029A2AC4-DB59-4F89-BFCF-19E0CAD221BE

P2093

Q39927735-28981FB9-3C55-4229-BD0D-2835DAFCA10B

Q39927735-828FC834-BA3D-4F63-AFAB-CE316A099330

Q39927735-AAAA4ABA-19C4-4487-AE91-12059354FB69

Q39927735-AC204205-F24D-4D09-B416-E45093ED01BB

Q39927735-B0EB7011-0585-40A7-8270-DA8B83F60419

Q39927735-D3DAC56E-DB16-4094-9C1A-6CE1E3AA0041

Q39927735-E3C7D722-9EB5-4A7A-9E4D-0C5DFC11AC3B

Q39927735-F202F932-99BD-4389-8602-E8C9A3B563E8

P2860

Q39927735-0B3A6C23-E255-4A39-8434-F9FC415D2829

Q39927735-1E640852-BF78-4602-AC47-397F86374FD1

Q39927735-2110865B-0AB5-4F04-81C9-9E2AD2D98011

Q39927735-23D76593-05DC-4690-8043-A0C5CAEF690F

Q39927735-26150187-43EA-4F87-9653-4DF080C49613

Q39927735-539840BD-4AAB-4395-8FB4-A51C8C54B499

Q39927735-55E1AB0B-9FF0-4A33-AB9D-0F5AA86E4F0C

Q39927735-5EDB2831-0AAB-41EB-A7B6-F5538E8368CA

Q39927735-688E34C7-30D9-4714-BA5B-5A5FA05C1BE8

Q39927735-75E6AA30-7A98-46DB-B72F-F64123E8DB8E

P2888

Q39927735-DBCE4D97-2FDE-4167-9127-23A73ECFC3AE

P304

Q39927735-A83B8421-EA29-46A9-BA0A-8E04F7339AC2

P31

Q39927735-8B1B2558-C3BA-4508-AAE0-EA1BD07235CB

P356

Q39927735-CF1BCB40-31BC-4739-8C02-CD0248566E2B

P407

Q39927735-2CE8EA43-5E27-4C9C-99A0-0453A18081F0

P433

Q39927735-C5E8DFC1-1E8C-4A81-A136-872524326A1F

P478

Q39927735-9F729631-0119-4BA9-B9CF-E2F62898761A

P577

Q39927735-76C45848-C2E0-4204-A1A0-62CF29C932D5

P5875

Q39927735-3FE9673B-9E24-45A9-B84F-5A17942D4611

P6179

Q39927735-BFE80730-571F-4CD5-995D-B84D4F96B184

P698

Q39927735-E492DE53-1EAB-443F-AEFD-7786BC0102F2

P921

Q39927735-1BA83F11-FC91-4A93-B7A0-9B67DC8E745D

Q39927735-EDC7C580-51BF-4134-8EB2-00696ACB468E

P932

Q39927735-A413BC81-C3F1-4419-A870-1C85C35337BB

P356

P1433

Nature Materials

P1476

Sustained release of a p38 inh ...... inhibits cardiac dysfunction.

@en

P2093

Gokulakrishnan Seshadri

http://www.w3.org/2001/XMLSchema#string

Jay C Sy

http://www.w3.org/2001/XMLSchema#string

Michael E Davis

http://www.w3.org/2001/XMLSchema#string

Milton Brown

http://www.w3.org/2001/XMLSchema#string

Niren Murthy

http://www.w3.org/2001/XMLSchema#string

Sergey Dikalov

http://www.w3.org/2001/XMLSchema#string

Stephen C Yang

http://www.w3.org/2001/XMLSchema#string

Teresa Oh

http://www.w3.org/2001/XMLSchema#string

P2860

Biomaterials for the Treatment of Myocardial Infarction

MEKK1 suppresses oxidative stress-induced apoptosis of embryonic stem cell-derived cardiac myocytes

Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle

Polyketal microparticles: a new delivery vehicle for superoxide dismutase

IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system

Direct evidence that oxygen-derived free radicals contribute to postischemic myocardial dysfunction in the intact dog.

Inhibition of p38 MAP kinase as a therapeutic strategy.

Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction.

Role of extracellular superoxide dismutase in hypertension.

Local myocardial insulin-like growth factor 1 (IGF-1) delivery with biotinylated peptide nanofibers improves cell therapy for myocardial infarction.

P2888

P304

863-868

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NMAT2299

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23395262

http://www.w3.org/2001/XMLSchema#string

P6179

1046441876

http://www.w3.org/2001/XMLSchema#string

P698

18931671

http://www.w3.org/2001/XMLSchema#string

P921

P932

2705946

http://www.w3.org/2001/XMLSchema#string